PROVEN
SKYRIZI RESULTS
Take Control of Ulcerative Colitis With Relief, Repair, and Remission
Already approved for adults with moderate to severe Crohn’s disease, SKYRIZI can deliver significant results in ulcerative colitis (UC).
In clinical trials, SKYRIZI helped patients experience remission at 12 weeks and 1 year.
*Based on fewer bowel movements and bloody stools.
†Areas that were visually assessed may not represent repair of the entire colon lining.
Feel Significant Symptom Relief
IN ONLY 4 WEEKS, 53% OF PEOPLE HAD:
Fewer Bowel Movements and Bloody Stools
+
Fewer Bloody Stools
AND AT 12 WEEKS:
No Bowel Movements During Sleep
67% had no accidents or bathroom trips during sleep.
No Bowel Urgency
Many had no bowel urgency.
Less Fatigue
People experienced significantly less UC fatigue.
Experience Early and Lasting Visible Colon Lining Repair
SKYRIZI patients who achieved visible colon lining repair† at:
12 WEEKS
In an induction trial,‡ SKYRIZI helped many people achieve visible colon lining repair† at 12 weeks.
36%
1200 mg starter IV§ infusion
1 YEAR
In a maintenance trial,|| among people who were eligible and entered, SKYRIZI helped the majority achieve visible colon lining repair† at 1 year.
51%
180 mg SC¶ maintenance injection
48%
Many achieved visible colon lining repair taking 360 mg SC¶
Your doctor will decide what maintenance dose is right for you.
Visible colon lining repair, also called “endoscopic improvement,” is a reduction in inflammation in the colon lining that your doctor can see—and controlling it is an important part of managing UC.
†Areas that were visually assessed may not represent repair of the entire colon lining.
See What SKYRIZI Repair Can Look Like
Before SKYRIZI
12 Weeks
1 Year
Real clinical trial endoscopy images from a patient who received SKYRIZI 1200 mg during induction and 180 mg during maintenance. Patient achieved visible colon lining repair at 12 weeks and 1 year.†
Individual results may vary.
Achieve Lasting Remission With SKYRIZI
SKYRIZI is proven to deliver early remission at 12 weeks and lasting remission at 1 year, which means few to no symptoms (like frequent bowel movements and bloody stools) and visible repair of the colon lining.
12
WEEKS
In an induction trial,‡ SKYRIZI helped some people achieve remission at 12 weeks.
1
YEAR
In a maintenance trial,|| among those who were eligible and entered, SKYRIZI helped many people achieve lasting remission at 1 year.
†Areas that were visually assessed may not represent repair of the entire colon lining.
‡Results are from a clinical trial of 646 people who took SKYRIZI.
§Intravenous infusion (through a vein in the arm).
|| 365 people who achieved a clinical response after 12 weeks of SKYRIZI induction and entered the maintenance trial. Clinical response is based on frequency of bowel movements, fewer bloody stools, and endoscopy results.
¶Subcutaneous injection (under the skin).
Up Next
Explore more about SKYRIZI, a biologic proven to help deliver results in UC.
Recommended for You
Learn how to make SKYRIZI part of your routine.
Answer 5 quick questions to better understand how UC is impacting you.